4.4 Article

Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis

Related references

Note: Only part of the references are listed.
Review Oncology

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Luis M. Seijo et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Editorial Material Medicine, General & Internal

GUIDELINES Lung cancer: diagnosis and management: summary of updated NICE guidance

Ross Maconachie et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Review Oncology

Update on screening for lung cancer

Douglas Arenberg

TRANSLATIONAL LUNG CANCER RESEARCH (2019)

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

Review Medicine, Research & Experimental

Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis

Hongbing Mei et al.

BIOMARKERS IN MEDICINE (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Oncology

Epidemiology of lung cancer in China

Maomao Cao et al.

THORACIC CANCER (2019)

Article Medicine, Research & Experimental

A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer

Hua Peng et al.

LIFE SCIENCES (2016)

Article Medicine, Research & Experimental

Long Noncoding RNA MALAT-1 Can Predict Poor Prognosis: A Meta-Analysis

Ruixue Tang et al.

MEDICAL SCIENCE MONITOR (2016)

Article Medicine, Research & Experimental

Expression of MALAT1 in the peripheral whole blood of patients with lung cancer

Fengjie Guo et al.

BIOMEDICAL REPORTS (2015)